Approaches to pharmacokinetic/pharmacodynamic modeling during pregnancy

Seminars in Perinatology

Volumn 25, Issue 3, 2001, Pages 124-132

  Wyska, Elzbieta ^a   Jusko, William J ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LABETALOL; NIFEDIPINE; RITODRINE; SUXAMETHONIUM;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG RECEPTOR BINDING; FEMALE; GENDER; HUMAN; MATHEMATICAL MODEL; PHARMACODYNAMICS; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034969045     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sper.2001.24905     Document Type: Conference Paper

References (15)

1. Convergence of direct and indirect pharmacodynamic response models
2. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy
3. Pharmacokinetics of succinylcholine in newborns
4. Succinylcholine pharmacodynamics in peripartum patients
5. Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients
6. Nifedipine pharmacokinetics and pharmacodynamics during the immediate postpartum period in patients with preeclampsia
7. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
8. Pharmacokinetics and pharmacodynamics of ritodrine after intramuscular administration to pregnant women
9. Comparison of four basic models of indirect pharmacodynamic responses
10. Pharmacokinetics and pharmacodynamics of TRH during pregnancy
11. Thyroid and antithyroid drugs
12. Role of baseline parameters in determining indirect pharmacodynamic responses
13. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics
14. Labetalol in hypertension during the third trimester of pregnancy: Its antihypertensive effect and pharmacokinetic-dynamic analysis
15. Study of single and multiple dose pharmacokinetic/pharmacodynamic modeling of the antihypertensive effect of labetalol